Cardiac Risk Factors and the Use of Triptans: A Survey Study

特里普坦 医学 偏头痛 急诊医学 儿科 内科学
作者
W. Young,Lisa K. Mannix,James U. Adelman,Aaron Shechter
出处
期刊:Headache [Wiley]
卷期号:40 (7): 587-591 被引量:33
标识
DOI:10.1046/j.1526-4610.2000.00091.x
摘要

Objective.—To describe current practice in triptan use. Background.—Triptans are effective migraine treatments that cause chest symptoms in some patients. True cardiac ischemia is rare. Design.—Headache specialists and family practitioners completed questionnaires regarding the times when triptans are contraindicated, obtaining electrocardiograms (ECGs), and giving the first dose in the office. Results.—Sixty‐five headache specialists and 67 family practitioners responded. Headache specialists saw an average of 36.3 patients with headache per week. Family practitioners saw an average of 7.2. Family practitioners and headache specialists had similar opinions regarding the age at which triptans were contraindicated with various numbers of risk factors. Sixty‐one percent of headache specialists and 50% of family practitioners would not use a triptan at any age for patients with more than three risk factors ( P = NS). Ten percent of headache specialists obtained an ECG for all patients being prescribed triptans, while no family practitioners did ( P = .008). Ten percent of both family practitioners and headache specialists never obtained an ECG, even with multiple cardiac risk factors. Headache specialists obtained ECGs more often than family practitioners ( P < .002 for one to three risk factors). Family practitioners were more likely to give the first dose of the triptan in the office regardless of cardiovascular risk (58% versus 20%, P < .001). Forty‐five percent of headache specialists and 2% of family practitioners never gave the first dose in the office ( P < .001). Family practitioners gave the first dose in the office more readily than headache specialists in patients with no risk factors ( P = .001), but not for one or more risk factors. Conclusions.—No consensus exists among family practitioners or headache specialists about when to avoid using a triptan due to excessive cardiac risk factors, when to obtain an ECG prior to using a triptan, and when to give the first dose of a triptan in the office. Headache specialists are more likely to obtain ECGs, whereas family practitioners are more likely to give the first dose of a triptan in the office.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
poegtam完成签到,获得积分10
刚刚
大胆盼兰发布了新的文献求助10
1秒前
wuyan204完成签到 ,获得积分10
2秒前
windcreator完成签到,获得积分10
2秒前
redondo5完成签到,获得积分0
2秒前
wangrswjx完成签到 ,获得积分10
2秒前
科研通AI5应助su采纳,获得10
2秒前
5秒前
7秒前
小二郎应助嘻嘻采纳,获得10
7秒前
yun完成签到 ,获得积分10
8秒前
8秒前
10秒前
健忘曼冬发布了新的文献求助10
10秒前
redondo完成签到,获得积分10
10秒前
momo完成签到,获得积分10
11秒前
希望天下0贩的0应助meng采纳,获得10
12秒前
龙歪歪发布了新的文献求助10
13秒前
13秒前
暮城完成签到,获得积分10
13秒前
14秒前
云墨完成签到 ,获得积分10
14秒前
16秒前
17秒前
Akim应助caoyy采纳,获得10
17秒前
18秒前
科研通AI2S应助DreamMaker采纳,获得10
18秒前
21秒前
zho发布了新的文献求助30
21秒前
21秒前
ywang发布了新的文献求助10
21秒前
ZD小草完成签到 ,获得积分10
22秒前
健忘曼冬完成签到,获得积分10
23秒前
hkl1542发布了新的文献求助50
24秒前
25秒前
26秒前
KYN完成签到,获得积分10
27秒前
27秒前
桐桐应助叶未晞yi采纳,获得10
27秒前
27秒前
高分求助中
Continuum Thermodynamics and Material Modelling 3000
Production Logging: Theoretical and Interpretive Elements 2700
Ensartinib (Ensacove) for Non-Small Cell Lung Cancer 1000
Unseen Mendieta: The Unpublished Works of Ana Mendieta 1000
Bacterial collagenases and their clinical applications 800
El viaje de una vida: Memorias de María Lecea 800
Luis Lacasa - Sobre esto y aquello 700
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 基因 遗传学 物理化学 催化作用 量子力学 光电子学 冶金
热门帖子
关注 科研通微信公众号,转发送积分 3527990
求助须知:如何正确求助?哪些是违规求助? 3108173
关于积分的说明 9287913
捐赠科研通 2805882
什么是DOI,文献DOI怎么找? 1540119
邀请新用户注册赠送积分活动 716941
科研通“疑难数据库(出版商)”最低求助积分说明 709824